Reviewed & approved by Dr. Nova Reyes · Last checked 2026-10-25. ← Back to Evidence Library
Epithalamin: what the evidence says
At a glance
What it is: a polypeptide extract from calf (bovine) pineal gland developed in the Soviet Union by V. Kh. Khavinson's group. It is not the same thing as epitalon, the synthetic four-amino-acid peptide (Ala-Glu-Asp-Gly) later designed from it. R1, R4
What the evidence says: developer-led Russian and Ukrainian studies in older people report lower death rates and changes in melatonin rhythm. Group assignment and controls are poorly described and the findings have not been repeated independently. R1, R2
Biggest risks: not well reported. It is an animal-tissue extract. Unknown
Rating
| Human Human evidence | Very limited: small developer-led studies in older adults with unclear controls R1, R2 |
| Animal Animal / lab evidence | Not rated here (longevity studies in flies, mice, rats reported by the same group R3) |
| Regulatory | Not FDA-approved (no Drugs@FDA record) · Russia: reported as registered in GRLS UNVERIFIED · WADA 2026: not named; S0 depends on Russian registration status UNVERIFIED |
| Established human dose | None recognized outside Russia. Study details lists what studies used where reported |
Evidence verdict: Human: Very limited Card verdict: Very limited (aging, developer-led Russian cohorts) Card note: Gray-market "epithalamin" or "epitalon" vials are a different product from the Russian extract in these studies.
This page reports what studies used. It is not dosing advice.
Legend: HUMAN data · ANIMAL / LAB data · UNKNOWN · UNVERIFIED: not yet confirmed against a primary source
About the evidence (developer-led): most of this literature comes from V. Kh. Khavinson's St. Petersburg Institute of Bioregulation and Gerontology and allied Russian, Ukrainian and Georgian groups. Many papers are short, Russian-language, and not independently repeated. Read the findings as the developers' own reports.
What is it?
Epithalamin is a mix of peptides extracted from the pineal gland, the small brain gland that makes melatonin. R1 Researchers later made a synthetic tetrapeptide, epitalon (also spelled epithalon), based on its amino-acid makeup; that has its own page. Results for one should not be assumed for the other. R4
Does it work?
- Human Long-term follow-up in older people: in 266 people followed 6–8 years, the authors report death rates 1.6–1.8 times lower with epithalamin and 2.5 times lower with epithalamin plus thymalin, compared with controls. How groups were assigned is not clear, and the authors lead the developer's institute. R1
- Human Melatonin rhythm: in healthy older people, night-time melatonin rose in those with low starting levels and tended to fall in those with normal levels. Patient numbers and controls are not given in the abstract. R2
- Animal Animals: the same group reports longer lifespan in fruit flies, mice and rats. R3
- Unknown Independent randomized trials outside Russia/Ukraine: none found.
Is it safe?
- Unknown Side effects are not described in the abstracts we read. R1, R2
- Unknown As an animal-gland extract, contamination and allergy are theoretical concerns.
Gray-market "research use only" Epithalamin: extra risks
Unknown contents. Vials sold online as "research use only" are not made under drug-quality rules, so identity, strength and sterility are unknown. This is a general caution; we have not found independent testing data for this product. Unknown Vendor claims about effects in people are marketing, not evidence. Unknown
What we don't know
- Unknown Whether the mortality findings hold up in independent randomized trials
- Unknown Side-effect rates
- Unknown Whether a gray-market vial labelled "epithalamin" contains the pineal extract or synthetic epitalon
Is it legal?
Not FDA-approved (no Drugs@FDA record, openFDA query Oct 25, 2026). Russia: reported as a registered medicine UNVERIFIED, not checked against the Russian State Register of Medicines (GRLS). EU, UK, Japan, China: UNVERIFIED not checked against EMA, MHRA, PMDA or NMPA. WADA: not named on the 2026 Prohibited List; S0 bans substances with no current governmental health-authority approval, which depends on Russian registration status UNVERIFIED.
Study details
These are amounts researchers used, not recommendations.
R1 Human Human: long-term follow-up in older people (Khavinson & Morozov 2003)
| Study | People / model | Route | Amount used | Follow-up | Reported | Side effects / limitations | Citation |
|---|---|---|---|---|---|---|---|
| Khavinson 2003 | 266 older people (thymalin, epithalamin, both, control) | Not in abstract | Not in abstract | 6–8 years (treatment first 2–3 years) | Mortality 1.6–1.8-fold lower (epithalamin) and 2.5-fold lower (with thymalin) vs control | Assignment method unclear; developer-led | PMID 14523363 |
R2 Human Human: melatonin rhythm in older people (Korkushko 2004)
Course treatment; amount and numbers not in abstract. Kiev Institute of Gerontology, with Khavinson as co-author. PMID 15452611
R3 Animal Animal: lifespan in flies, mice, rats (Anisimov 1998)
R4 Review of epitalon (2025)
Full reference list (PubMed entries checked Oct 25, 2026)
- Khavinson VKh, Morozov VG. Neuro Endocrinol Lett. 2003;24(3-4):233-40. PMID 14523363
- Korkushko OV, et al. Bull Exp Biol Med. 2004;137(4):389-91. PMID 15452611
- Anisimov VN, et al. Mech Ageing Dev. 1998. Pineal peptide preparation epithalamin increases the lifespan of fruit flies, mice and rats. PMID 9701766
- Araj SK, et al. Int J Mol Sci. 2025. Overview of Epitalon. PMID 40141333
Disclaimer
This page is for education and harm reduction, not medical advice or a recommendation to use Epithalamin. Talk to a clinician you trust before using any drug, and report problems to FDA MedWatch (https://www.fda.gov/safety/medwatch).
Approved for Adam Greene by Dr. Nova Reyes, 2026-10-25.